Clinical Trials
18 trialsNCT07285044 2026-05-18
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mayo Clinic
Phase 2 Recruiting
NCT05652335 2026-05-08
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Janssen Research & Development, LLC
Phase 1 Recruiting
NCT05145816 2026-05-07
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
University of Texas Southwestern Medical Center
Phase 1/2 Recruiting
NCT04839003 2026-04-16
ReAL
Fondazione IRCCS Policlinico San Matteo di Pavia
Recruiting
NCT05444920 2026-03-27
ITA-WebNet
Fondazione IRCCS Policlinico San Matteo di Pavia
Recruiting
NCT07081646 2026-03-24
ALACRITY
Alexion Pharmaceuticals, Inc.
Phase 1/2 Recruiting
NCT07172243 2026-02-27
BE.Amycon Biobank & Data Registry UZ Leuven
Universitaire Ziekenhuizen KU Leuven
Recruiting
NCT06573723 2026-01-14
Institutional Registry of Rare Diseases
Hospital Italiano de Buenos Aires
Recruiting
NCT04991103 2025-12-31
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
University of Alabama at Birmingham
Phase 2 Recruiting
NCT05556928 2025-12-08
CARE-Heme
University of Alabama at Birmingham
Recruiting
NCT03717844 2025-11-20
Registry for Adults With Plasma Cell Disorders (PCD's)
UNC Lineberger Comprehensive Cancer Center
Recruiting
NCT02641145 2025-11-14
MICA
Brigham and Women's Hospital
Phase NA Recruiting
NCT06887283 2025-08-21
EAR
University Hospital, Essen
Recruiting
NCT06097832 2025-07-10
NEXICART-2
Nexcella Inc.
Phase 1/2 Recruiting
NCT06539169 2024-11-14
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
xCures
Recruiting
NCT05635266 2024-05-07
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Sanguine Biosciences
Recruiting
NCT06376214 2024-04-19
Daratumumab for Patients With Light Chain Amyloidosis
Nanjing University School of Medicine
Phase NA Recruiting
NCT05283993 2022-04-25
A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
Peking University First Hospital
Recruiting